Results 291 to 300 of about 2,633,569 (375)

Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer

open access: yesAdvanced Science, EarlyView.
Corticosteroids improve the efficacy of immune checkpoint blockade therapy in metastatic murine breast cancer. By normalizing the tumor immune microenvironment, corticosteroids reduce immunosuppressive signals, restore T‐cell function, and promote antitumor immune responses, resulting in enhanced tumor control.
John D. Martin   +19 more
wiley   +1 more source

The Role of Angiogenetic Factors in Preeclampsia. [PDF]

open access: yesInt J Mol Sci
Papapanagiotou A   +6 more
europepmc   +1 more source

Plasma Levels of VEGF-C and Soluble VEGF Receptor-3 are Elevated in Neovascular AMD

open access: green, 2017
Gianna C Teague   +4 more
openalex   +1 more source

VEGF ligand-receptor interactions

open access: yesReactome - a curated knowledgebase of biological pathways, 2008
S Krupa, G Gopinathrao
openaire   +1 more source

PBLD Orchestrates the STING‐Mediated Antiviral Immune Response and Autoimmune Diseases

open access: yesAdvanced Science, EarlyView.
During viral infection, PBLD expression is downregulated, thereby subverting host antiviral defenses and promoting viral replication. This study identifies PBLD as a positive regulator of STING‐induced type I interferon activation and delineated the molecular network underlying PBLD‐mediated antiviral immunity and autoimmune pathogenesis, highlighting ...
Peili Hou   +17 more
wiley   +1 more source

Immunomodulatory Role of Propolis in Hypoxia and in the Tumor Microenvironment. [PDF]

open access: yesMolecules
Kłósek M   +5 more
europepmc   +1 more source

Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents

open access: bronze, 2010
Hitoshi Yoshiji   +16 more
openalex   +2 more sources

Nanomedicines Against Mitochondrial Dysfunction‐Induced Metabolic Diseases

open access: yesAdvanced Science, EarlyView.
Mitochondrial dysfunction is central to metabolic diseases. Nanomedicine offers transformative approaches for restoring function via targeted delivery, responsive release, and multimodal therapy. This review outlines the pathological basis, nanocarrier design, organelle‐specific targeting, recent advances, and future clinical translation challenges ...
Ke Xu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy